Escherichia coli ST131: a multidrug-resistant clone primed for global domination

F1000Research - Tập 6 - Trang 195
Johann Pitout1,2,3,4, Rebekah DeVinney2
1Department of Medical Microbiology, University of Pretoria, Pretoria
2Departments of Microbiology, Immunology, and Infectious Diseases, Cummings School of Medicine, University of Calgary, Calgary, Alberta
3Departments of Pathology and Laboratory Medicine, Cummings School of Medicine, University of Calgary, Calgary
4Division of Microbiology, Calgary Laboratory Services, Calgary, Alberta

Tóm tắt

A single extra-intestinal pathogenic Escherichia coli (ExPEC) clone, named sequence type (ST) 131, is responsible for millions of global antimicrobial-resistant (AMR) infections annually. Population genetics indicate that ST131 consists of different clades (i.e. A, B, and C); however, clade C is the most dominant globally. A ST131 subclade, named C1-M27, is emerging in Japan and has been responsible for the recent increase in AMR ExPEC in that country. The sequential acquisition of several virulence and AMR genes associated with mobile genetic elements during the 1960s to 1980s primed clade C (and its subclades C1 and C2) for success in the 1990s to 2000s. IncF plasmids with F1:A2:B20 and F2:A1:B replicons have shaped the evolution of the C1 and C2 subclades. It is possible that ST131 is a host generalist with different accessory gene profiles. Compensatory mutations within the core genome of this clone have counterbalanced the fitness cost associated with IncF plasmids. ST131 clade C had dramatically changed the population structure of ExPEC, but it still remains unclear which features of this clade resulted in one of the most unprecedented AMR successes of the 2000s.

Từ khóa


Tài liệu tham khảo

J Pitout, 2012, Extraintestinal Pathogenic Escherichia coli: A Combination of Virulence with Antibiotic Resistance., Front Microbiol., 3, 9, 10.3389/fmicb.2012.00009

J Pitout, 2012, Extraintestinal pathogenic Escherichia coli: an update on antimicrobial resistance, laboratory diagnosis and treatment., Expert Rev Anti Infect Ther., 10, 1165-76, 10.1586/eri.12.110

2014, Antimicrobial resistance: global report on surveillance 2014, 257

J Pitout, 2008, Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern., Lancet Infect Dis., 8, 159-66, 10.1016/S1473-3099(08)70041-0

M Nicolas-Chanoine, 2014, Escherichia coli ST131, an intriguing clonal group., Clin Microbiol Rev., 27, 543-74, 10.1128/CMR.00125-13

N Petty, 2014, Global dissemination of a multidrug resistant Escherichia coli clone., Proc Natl Acad Sci U S A., 111, 5694-9, 10.1073/pnas.1322678111

N Stoesser, 2016, Evolutionary History of the Global Emergence of the Escherichia coli Epidemic Clone ST131., MBio., 7, e02162, 10.1128/mBio.02162-15

N Ben Zakour, 2016, Sequential Acquisition of Virulence and Fluoroquinolone Resistance Has Shaped the Evolution of Escherichia coli ST131., MBio., 7, e00347-16, 10.1128/mBio.00347-16

G Peirano, 2014, Fluoroquinolone-resistant Escherichia coli sequence type 131 isolates causing bloodstream infections in a canadian region with a centralized laboratory system: rapid emergence of the H30-Rx sublineage., Antimicrob Agents Chemother., 58, 2699-703, 10.1128/AAC.00119-14

A Carattoli, 2009, Resistance plasmid families in Enterobacteriaceae., Antimicrob Agents Chemother., 53, 2227-38, 10.1128/AAC.01707-08

J Shin, 2012, Replicon sequence typing of IncF plasmids and the genetic environments of blaCTX-M-15 indicate multiple acquisitions of blaCTX-M-15 in Escherichia coli and Klebsiella pneumoniae isolates from South Korea., J Antimicrob Chemother., 67, 1853-7, 10.1093/jac/dks143

Z Zong, 2013, Complete sequence of pJIE186-2, a plasmid carrying multiple virulence factors from a sequence type 131 Escherichia coli O25 strain., Antimicrob Agents Chemother., 57, 597-600, 10.1128/AAC.01081-12

A Mathers, 2015, The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae., Clin Microbiol Rev., 28, 565-91, 10.1128/CMR.00116-14

T Johnson, 2016, Separate F-Type Plasmids Have Shaped the Evolution of the H30 Subclone of Escherichia coli Sequence Type 131., mSphere., 1, 10.1128/mSphere.00121-16

Y Matsumura, 2015, CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic., J Antimicrob Chemother., 70, 1639-49, 10.1093/jac/dkv017

Y Matsumura, 2016, Global Escherichia coli Sequence Type 131 Clade with blaCTX-M-27 Gene., Emerging Infect Dis., 22, 1900-7, 10.3201/eid2211.160519

R Banerjee, 2013, Molecular epidemiology of Escherichia coli sequence type 131 and Its H30 and H30-Rx subclones among extended-spectrum-β-lactamase-positive and -negative E. coli clinical isolates from the Chicago Region, 2007 to 2010., Antimicrob Agents Chemother., 57, 6385-8, 10.1128/AAC.01604-13

A McNally, 2016, Combined Analysis of Variation in Core, Accessory and Regulatory Genome Regions Provides a Super-Resolution View into the Evolution of Bacterial Populations., PLoS Genet., 12, e1006280, 10.1371/journal.pgen.1006280

D Andersson, 2010, Antibiotic resistance and its cost: is it possible to reverse resistance?, Nat Rev Microbiol., 8, 260-71, 10.1038/nrmicro2319

R Banerjee, 2014, A new clone sweeps clean: the enigmatic emergence of Escherichia coli sequence type 131., Antimicrob Agents Chemother., 58, 4997-5004, 10.1128/AAC.02824-14

Thông tin
Thông tin xuất bản

F1000Research

Tập 6

195

Thông tin tác giả